… clinical impact of EGFR mutation in patients with adenocarcinoma of the lung and who had
… predict the clinical outcomes of patients with lung adenocarcinoma after curative resection. …

… of KRAS mutations in lung cancer and contrast these with the features of EGFR mutations. …
Recent large-scale analysis of somatic mutations in lung adenocarcinoma also confirmed …

… EGFR mutations are detected in the lung adenocarcinomas of Japanese patients more …
frequency of EGFR mutations ranges from 40 to 60 % in Japanese lung adenocarcinomas [8…

… of EGFR mutation, we established that KRAS mutations … KRAS mutations with mucinous
BAC. Furthermore, multiple studies have suggested that EGFR mutations and KRAS mutations …

… lung adenocarcinoma, and whose tumor harbored either KRAS codon 12 mutations or EGFR
gene mutations … KRAS codon 12 mutations and EGFR mutations were mutually exclusive. …

… Lung adenocarcinomas also harbor activating mutations in … oncogene (KRAS), and mutations
in EGFR and KRAS appear … of KRAS mutations, which varies from that of EGFR mutations. …

… -TKIs or placebo).13, 14 However, we identified previously that EGFR mutations did not …
EGFR, KRAS, and TP53 mutations among a large cohort of patients with lung adenocarcinomas …

… -existing mutations of EGFR and KRAS in lung adenocarcinoma (Figure 1F). Likewise,
mutations in NF1, a suppressor of RAS activity, were negatively associated with EGFR mutations …

… classification of lung adenocarcinomas and EGFR and KRAS mutation status. … EGFR
mutations and 158 cases were examined for KRAS mutations, and the EGFR and KRAS mutations …

… to EGFR-targeted therapies, and adverse prognosis. Whether KRAS-mutated lung
adenocarcinomas … We tested 180 resected lung adenocarcinomas for KRAS and EGFR mutations …